Forum LABO Paris 2027

LR

Leonie REDT

Zymo Research Europe GmbH

Scientific Support Manager

This speaker will talk about

Find here the list of all the sessions presented by this speaker in order not to miss any of it.
Atelier Exposant - Salle 2
Mar 24, 2027
2:15 PM2:45 PM
Biotechnology, science and healthcare of tomorrowInnovation and scientific valorization

Capture More: Improving Sensitivity and Accuracy in cfDNA Sequencing

Speakers:
Valentina LO REOZYMEChef de produits biologie moléculaire - TransfectionLeonie REDTZymo Research Europe GmbHScientific Support Manager
Description
Capture More: Improving Sensitivity and Accuracy in cfDNA Sequencing Liquid biopsy offers a minimally invasive way to investigate disease-associated changes through circulating cell-free DNA (cfDNA), with applications in cancer detection, tissue-of-origin analysis and disease monitoring. However, cfDNA is scarce, highly fragmented and heterogeneous, making efficient recovery and reliable library preparation essential for sensitive and accurate analysis. This presentation focuses on an integrated workflow addressing two key challenges. - First, special magnetic-bead extraction chemistry enables recovery of a broad cfDNA size range. This includes very short fragments that are often missed by conventional extraction methods, although they can contain important information. - Second, a native-end-preserving library preparation strategy based on Splinted Ligation Adapter Tagging (SPLAT) enables direct adapter ligation without end repair. By avoiding enzymatic modification of DNA ends, this approach helps preserve native fragment termini, reduce processing-related biases and retain valuable information from short, nicked or damaged molecules. For epigenetic studies, the workflow can be complemented by whole-genome bisulfite sequencing (WGBS), enabling genome-wide DNA methylation profiling from low-input cfDNA. Together, these approaches provide access to complementary layers of information beyond genetic alterations, including fragment lengths, native DNA ends and methylation patterns. Combining these insights may support more sensitive and informative approaches to early cancer detection, tissue-of-origin analysis and disease monitoring. Key Takeaways • Recover more: Capture a broader range of cfDNA fragment sizes, including very short fragments. • Preserve more: Avoid end repair to retain native DNA ends and minimize processing-related biases • Discover more: Combine genetic, epigenetic and fragmentomic insights through complementary sequencing approaches.
OZYME
Loading